Search Results 691-700 of 19238 for hemoglobin

  1. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

    Participation eligibility · Hemoglobin ≥9.0 g/dL · Absolute neutrophil count (ANC) ≥1500/mm3 · Platelet count ≥100,000/mm3 · Creatinine ≤1.5 x ULN OR measured ...

  2. Trial Of Neoadjuvant Enoblituzumab Vs SOC In Men With High-Risk Localized Prostate Cancer - Mayo Clinic

    - Hemoglobin >9.0 g/dL - Platelet count >100,000 cells/mm3 - Serum creatinine <1.5 × upper limit of normal (ULN) - Serum bilirubin <1.5 × ULN - ALT <3 × ULN

  3. Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression - Mayo Clinic

    hemoglobin greater than or equal to 9 g/dl;; aspartate aminotransferase (AST) and alanine aminotransferase (ALT) less than 3 times the upper limit of normal ...

  4. Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA - Mayo Clinic

    Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable); Total bilirubin =< 1.5 x ...

  5. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. - Mayo Clinic

    Hemoglobin > 8 g/dL;; Resolved acute effects of any prior therapy to baseline severity or Common Terminology Criteria for Adverse Events (CTCAE) Grade < 1 ...

  6. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer - Mayo Clinic

    Participation eligibility · Absolute neutrophil count (ANC) ≥1500/mm3 · Platelets ≥100,000/dL · Hemoglobin ≥9 g/dL · Bilirubin ≤1.5 mg/dL · Serum creatinine ≤ ...

  7. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone - Mayo Clinic

    Hemoglobin ≥ 10 g/dL;; Serum Creatinine < 2.0 mg/dL [176.8 µmol/liter];; Serum calcium ≤ 11.5 mg/dL;; Calc. Creatinine Clearance > 50 mL/min;; Bilirubin ...

  8. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

    - Hemoglobin (Hgb) level ≤10.0 grams/deciliter (pre-transfusion). - Evidence of classical complement pathway activation. - Evidence of active hemolysis ...

  9. Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes - Mayo Clinic

    Subject has Glycosylated hemoglobin (HbA1c) > 8.5 % at time of screening. Note: All HbA1c blood specimens will be sent to and tested by a NGSP certified ...

  10. Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B - Mayo Clinic

    Platelet count <90,000 /mm3, hemoglobin <13 g/dL (males) or <12 g/dL (females), absolute neutrophil count <1500 /mm3 (<1000/mm3 for African-Americans) within 8 ...